Zobrazeno 1 - 10
of 19
pro vyhledávání: '"I N Kogarko"'
Autor:
L V Kozlovskaya, V V Rameev, T V Androsova, I N Kogarko, B S Kogarko, N N Mrykhin, I G Rekhtina
Publikováno v:
Терапевтический архив, Vol 88, Iss 12, Pp 82-87 (2016)
The article deals with the so-called monoclonal gammopathy of undetermined significance (MGUS), which is being actively explored in the world and has been recently investigated in Russia. It indicates the principles of identifying the phenotypes of M
Externí odkaz:
https://doaj.org/article/456fd0bd76a54e07bd3394202e26933d
Publikováno v:
Терапевтический архив, Vol 87, Iss 6, Pp 108-111 (2015)
It is currently well justified that monoclonal gammopathies are the most important predictor for kidney diseases, including glomerulonephritis. To determine a correlation of nephropathy with oligosecretory gammopathy is of fundamental importance, as
Externí odkaz:
https://doaj.org/article/dafa1f82e98448d9bfbf58fbd16fafd6
Autor:
Vilen Vilevich Rameev, Lidiya Vladimirovna Kozlovskaya, Elena Aleksandrovna Malinina, Anna Grigor'evna Serova, Ivetta Nikolaevna Kogarko, Bronislav Stanislavovich Kogarko, Nina Vasil'evna Lyubimova, V V Rameev, L V Kozlovskaya, E A Malinina, A G Serova, I N Kogarko, B S Kogarko, N V Lyubimova
Publikováno v:
Терапевтический архив, Vol 83, Iss 8, Pp 48-54 (2011)
Aim. To determine clinical significance of measuring blood levels of protein precursors of AA- and AL-amyloidosis - SAA and immunoglobulin free light chains (ILC), respectively. Material and methods. SAA concentrations were studied with ELISA in 43 r
Externí odkaz:
https://doaj.org/article/5821d029259d43a2bdbeadbe21c17514
Publikováno v:
Терапевтический архив, Vol 82, Iss 6, Pp 29-32 (2010)
Aim: to define the clinical value of various concentrations of immunoglobulin light chains (ILCs) in patients with AL amyloidosis. Subjects and methods. The content of free ILCs was studied by a nephelometric technique after their fixation in the blo
Externí odkaz:
https://doaj.org/article/47ce9473f6734c619e70f03583ea918f
Autor:
Anatoliy Konstantinovich Golenkov, Tat'yana Alekseevna Mitina, Ivetta Nikolaevna Kogarko, Nina Vasil'evna Lyubimova, Elena Fedorovna Klinushkina, Anatoliy Yur'evich Baryshnikov, A K Golenkov, T A Mitina, I N Kogarko, N V Lyubimova, E F Klikushkina, A Yu Baryshnikov
Publikováno v:
Терапевтический архив, Vol 81, Iss 7, Pp 37-41 (2009)
Aim. To ascertain individual sensitivity to veikeid in patients with resistant and recurrent multiple myeloma (MM) by determination of free light chains (FLC) of serum immunoglobulins. Material and methods. Forteen patients with MM stage III (Gcappa-
Externí odkaz:
https://doaj.org/article/8f9d4f0217fc4eca82cfca274c253e15
Autor:
T. A. Мitina, A. K. Golenkov, A. Yu. Baryshnikov, A. V. Karaulov, E. V. Trifonova, Yu. B. Chernykh, E. V. Katayeva, T. D. Lutskaya, L. L. Vysotskaya, G. A. Dudina, S. G. Zacharov, A. M. Fomin, N. V. Lyubimova, I. N. Kogarko
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 0, Iss 29, Pp 33-37 (2016)
Efficiency of the multiple myeloma treatment with chemotherapy including bortezomib was assessed based on determination of the level of immunoglobulin free light chains in blood serum. The method enables estimation of changes in kinetic parameters of
Externí odkaz:
https://doaj.org/article/05d3dfcce4404fb0a35c81461490811c
Autor:
I. I. Pelevina, A. V. Akleev, I. N. Kogarko, V. V. Petushkova, B. S. Kogarko, E. A. Pryakhin, E. A. Neifakh, O. V. Ktitorova, S. S. Andreev
Publikováno v:
Russian Journal of Physical Chemistry B. 15:1046-1053
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::adf2ab9dd188239c402a11475b88b23a
https://doi.org/10.1134/s1990793121060233
https://doi.org/10.1134/s1990793121060233
Autor:
Natalia Chebotareva, I. N. Kogarko, V. V. Varshavsky, L. B. Lysenko, S. V. Roshchupkina, N. N. Mrykhin, V V Rameev, T V Androsova
Publikováno v:
Nephrology (Saint-Petersburg). 23:82-90
BACKGROUND. Мonoclonal gammopathy (MG) is not only the state preceding of hematological neoplasms, but also associated with non- hematological diseases, in particular damage of kidneys. Earlier diagnosis of MG represents an important area in treatin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::920b1aa17e25ec8e74bd960da10b91e8
https://doi.org/10.24884/1561-6274-2019-23-2-82-90
https://doi.org/10.24884/1561-6274-2019-23-2-82-90
Autor:
S V Roshchupkina, Natalia Chebotareva, I. N. Kogarko, L V Kozlovskaya, T V Androsova, S. A Maryina, N. N. Mrykhin, V V Rameev, B S Kogarko
Publikováno v:
Terapevticheskii arkhiv. 91(6)
Monoclonal gammopathy (MG) is not only the state preceding of hematological neoplasms, but also associated with non - hematological diseases, in particular kidney damage.To assess the diagnostic value of "Freelite" methods in addition to electrophore
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bded8e95bd103c558fb0cade117cfa31
https://pubmed.ncbi.nlm.nih.gov/36471598
https://pubmed.ncbi.nlm.nih.gov/36471598
Autor:
A V Russkikh, N. N. Mrykhin, V V Rameev, O. A. Loshkareva, I. N. Kogarko, N. B. Gordovskaya, L V Kozlovskaya, Natalia Chebotareva, T V Androsova, E. I. Sidorova, S. V. Roshchupkina
Publikováno v:
Clinical Medicine (Russian Journal). 94:892-901
The term «monoclonal gammopathies of undetermined significance» (MGUS) was introduced by R. Kyle in 1978 to designate the condition characterized by the presence ofsmall amounts ofM-protein in the serum. In some patients, such condition remains ben
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a882833ddf5799bd27c752446451526
https://doi.org/10.18821/0023-2149-2016-94-12-892-901
https://doi.org/10.18821/0023-2149-2016-94-12-892-901